A FARETES study of the efficacy and safety of testosterone in metastatic renal cell carcinoma patients with fatigue

Category Primary study
JournalJournal of Clinical Oncology
Year 2018
This article has no abstract
Epistemonikos ID: a54fcc1fdbe25ae906b62c4f7d2867189853fe49
First added on: Feb 10, 2025